Tonix Pharmaceuticals Prices $4.4M Registered Direct Offering Of 14,666,666 Shares And Warrants At $0.30/Share; Warrants Have Exercise Price Of $0.33/Share
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals has announced a registered direct offering of 14,666,666 shares and warrants, priced at $0.30 per share. The warrants have an exercise price of $0.33 per share, raising a total of $4.4 million.

March 28, 2024 | 1:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tonix Pharmaceuticals' direct offering could dilute current shareholders but provides capital for operations or growth.
Direct offerings often lead to dilution of existing shares, potentially lowering the stock price in the short term. However, the capital raised can be crucial for the company's operations or growth initiatives. The specific details of the offering, such as the price per share and the exercise price of the warrants, are critical for investors to consider.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100